PI
PCVX icon

Putnam Investments’s Vaxcyte PCVX Stock Holding History

Putnam Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$14.3M Buy
227,118
+120,705
+113% +$6.27M 0.02% 275
2023
Q3 		$5.42M Buy
106,413
+15,670
+17% +$773K 0.01% 417
2023
Q2 		$4.53M Buy
+90,743
New +$4.3M 0.01% 473

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's PCVX Position: Q4 2023 in Review

Putnam Investments increased its Vaxcyte (PCVX) stake by 113% in Q4 2023, buying an estimated $6.27M and bringing the position to 227,118 shares worth $14.3M. The position accounts for 0.02% of the portfolio, ranked #275.

Putnam Investments first reported a position in PCVX in Q2 2023 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold PCVX as of Q4 2023.

  • Putnam Investments held 227,118 shares of Vaxcyte worth $14.3M as of Q4 2023.
  • Putnam Investments bought 120,705 Vaxcyte shares in Q4 2023, an estimated $6.27M.
  • Vaxcyte made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #275 holding.
  • Putnam Investments first reported a position in Vaxcyte in Q2 2023 and has held it in 3 quarters since.
  • 223 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.